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Introduction
The PFAPA syndrome is a non-mendelian autoinflam-
matory disease of unknown aetiology characterized by
Periodic Fever, Aphthous stomatitis, Pharyngitis, and
cervical Adenitis. In typical cases, attacks begin before
the age of five and occur every 2-8 weeks, often with
striking periodicity. We have previously profiled the
blood cells and serum cytokine levels in a cohort study
of patients with PFAPA (Brown et al, BMC Pediatric
2010). Since autoinflammatory diseases by definition are
mediated by cells of the innate immune system, and the
major innate immune cell, the neutrophil, is abundant
in the circulation during PFAPA episodes we decided to
investigate neutrophil function during the febrile and
afebrile state in the same cohort.
Objectives
The purpose of this study was to characterize functional
features of neutrophils, during different phases PFAPA
syndrome, including priming, production of reactive
oxygen species (ROS), and apoptosis.
Methods
Neutrophils (PMN) were isolated from blood collected
from twelve PFAPA patients during febrile and afebrile
phases (mean age 3.5 yrs), from 18 healthy control chil-
dren (mean age 4.5 yrs), and from 4 febrile control chil-
dren (mean age 4.8 yrs), with fever and abdominal pain
due to infection or appendicitis. We assessed PMN
apoptosis by annexin V staining, production of reactive
oxygen species (ROS) by luminol/isoluminol-amplified
chemiluminescence, MPO quantity by ELISA, and
degranulation/priming as expression of CD11b and
L-selectin by flow cytometry.
Results
We found a significantly increased intracellular (ic) pro-
duction of ROS in response to PMA in PMN during the
febrile phase, as compared to cells from the afebrile
phase. No differences were found in MPO quantity
between the samples indicating that the increase in
icROS was due to increased NADPH-oxidase activation.
We also found decreased spontaneous apoptosis in
PMN during the febrile phase of PFAPA, while apopto-
sis was instead increased during the afebrile phase.
Increased expression of CD11b indicated that the PMN
were slightly primed during the febrile phase, supported
by increased oxidative response to galectin-3, a priming-
dependent process. Preliminary results indicate that the
latter are not general features of PMN in children with
fever, as the febrile control children were significantly
lower in degranulation as well as galectin-3-induced
ROS production.
Conclusion
Alterations in PMN function, e.g., icROS-production,
priming and spontaneous apoptosis, may give mechanis-
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